Many general and specialized ophthalmologic methods are available to evaluate patients for presbyopia. Far distance visual acuity is typically evaluated at 6 meters and can be tested with traditional ...
Xelafaslatide is a small-molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death that occurs across multiple retinal diseases and conditions. ONL ...
A pioneering retinal implant has successfully restored central vision in patients with advanced age-related macular degeneration (AMD), according to a peer-reviewed study published in the New England ...
A Prescription Drug User Fee Act target date of February 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
PARIS--(BUSINESS WIRE)--Regulatory News: ... direct injection of lenadogene nolparvovec may be more effective than the contralateral therapeutic effect ... The paper, published in the July 2025 issue ...
Please provide your email address to receive an email when new articles are posted on . Dyop and ETDRS results were comparable under photopic conditions. However, Dyop results were worse under mesopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results